-+ 0.00%
-+ 0.00%
-+ 0.00%

Istazolam tablets from a subsidiary of Unicyclic Pharmaceuticals (600513.SH) passed the consistency evaluation

Zhitongcaijing·12/04/2025 08:49:03
Listen to the news

Zhitong Financial App News, Lianhuan Pharmaceutical (600513.SH) issued an announcement. Xinxiang Changle Pharmaceutical Co., Ltd. (“Changle Pharmaceutical”), a holding subsidiary of the company, recently received the approval and issuance of the “Drug Supplement Application Approval Notice” for isazolam tablets from the State Drug Administration to approve Changle Pharmaceutical's product to pass the consistent evaluation of generic drug quality and efficacy.

Exazolam tablets are mainly used to fight anxiety and insomnia. It is also used for tension, fear, and anti-seizure and anticonvulsants. This drug is a commonly used clinically commonly used benzodiazepine sedative and hypnotic drug.